The US FDA study is intended to evaluate the system for treating life-threatening ventricular tachyarrhythmias.

Researchers report favorable safety and efficacy for a combination device after implantation and at 6 months follow-up among ...

Y2K came and went, and it was quite a letdown for the “gloom and doomers.” Amidst the hype, it seemed like Y2K would have a huge impact on many aspects of our daily lives, but the clock struck 12:01 ...

Presenting data last week at the American Heart Association 2006 Scientific Sessions, lead investigator Dr Christine Albert (Harvard Medical School, Boston, MA) and colleagues report that acute ...